Predictive Oncology appoints Julia Kirshner CSO, consolidates R&D to Pittsburgh

Axe Compute Inc.

Julia Kirshner, Ph.D., appointed Chief Scientific Officer effective Aug 1, 2022; previously SVP and President of zPREDICTA.
Employment agreement includes $380k base salary, bonus eligibility, 150,000 RSU LTIP, and $380k cash bonus if employed through July 2025.
TumorGenesis division relocating from Salem, MA to Pittsburgh, PA; consolidation expected by Sept 30, 2022.
Estimated restructuring costs of $250k for lease buyout and employee termination; two positions eliminated.
Pittsburgh lab space expanding to accommodate growth and R&D activities.

item 2.05 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julia Kirshner

Chief Scientific Officer

AGPU · Axe Compute Inc.

Effective: 2022-08-01
Filed: July 26, 2022, 7:59 PM ET

On July 26, 2022 the Company announced that Julia Kirshner, Ph.D., has been appointed Chief Scientific Officer of the Company, effective August 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Julia Kirshner was appointed as Chief Scientific Officer at Axe Compute Inc..

Action: appointed
Role: Chief Scientific Officer

Exact text from the filing

On July 26, 2022 the Company announced that Julia Kirshner, Ph.D., has been appointed Chief Scientific Officer of the Company, effective August 1, 2022.

View on SEC.gov

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-22-004989

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.